BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Transcription profiling by array of human umbilical cord blood cells with Leukemia fusion-genes

Dataset: Transcription profiling by array of human umbilical cord blood cells with Leukemia fusion-genes

MLL-AF9 expression in normal human umbilical cord blood CD34+ cells leads to long-term proliferation of a myeloid progenitor cell with...

Registered by ArrayExpress Uploader
View Dataset

MLL-AF9 expression in normal human umbilical cord blood CD34+ cells leads to long-term proliferation of a myeloid progenitor cell with leukemogenic potential. Expression of a Core Binding Factor leukemia fusion (AML1-ETO or CBFbeta-SMMHC) in human CD34+ cells results in self-renewal of primitive progenitor cells with multilineage potential and stem cell ability, but these cells do not induce leukemia in immunodeficient mice. This comparative microarray study was initiated to determine how faithful these cell cultures are to the transcriptome of patient samples expressing each of these different fusion proteins, and to analyze the signaling pathways that are unique to CBF cultures and MLL-fusion cultures, with the hope of determining why the MLL-fusion cells are leukemogenic while the CBF cells are not. Experiment Overall Design: We have established a culture system whereby we retrovirally transduce human CD34+ cells, obtained from cord blood, with the leukemia fusion genes MLL-AF9 (MA9), AML1-ETO (AE) or CBFbetaMYH11 (CM). Cells expressing each of these fusion proteins are able to proliferate long-term in vitro in a cytokine dependent manner. These cultures resemble somewhat the blast samples from patients that contain these different fusion proteins, in that MA9 cells are predominantly monocytic (M5-like), AE cells have a large population of primitive CD34+ cells with continued abnormal differentiation (M2-like) and CM cells also contain a population of primitive CD34+ cells with continued abnormal differentiation but also have a significant population of abnormal eosinophils (M4Eo). We grow these cells in the presence of fetal bovine serum (FBS), and also grow them in serum-free conditions using the BIT supplement from Stem Cell Technologies. For the current experiments we used cell cultures that had been proliferating in vitro for 8-12 weeks, in either serum-free conditions or with FBS. Replicate samples were included in some instances, and the same clonal cultures that were grown under either BIT or FBS were also included.

Species:
human

Samples:
18

Source:
E-GEOD-7011

PubMed:
18538732

Updated:
Dec.12, 2014

Registered:
Sep.21, 2014


Factors: (via ArrayExpress)
Sample growth condition genotype
GSE7011GSM161805 serum free AML1-ETO
GSE7011GSM161805 serum free AML1-ETO
GSE7011GSM161805 serum free AML1-ETO
GSE7011GSM161805 serum free AML1-ETO
GSE7011GSM161812 with serum AML1-ETO
GSE7011GSM161805 serum free AML1-ETO
GSE7011GSM161809 serum free CBFbeta-MYH11
GSE7011GSM161809 serum free CBFbeta-MYH11
GSE7011GSM161809 serum free CBFbeta-MYH11
GSE7011GSM161817 serum free MLL-AF9
GSE7011GSM161817 serum free MLL-AF9
GSE7011GSM161813 with serum MLL-AF9
GSE7011GSM161817 serum free MLL-AF9
GSE7011GSM161817 serum free MLL-AF9
GSE7011GSM161813 with serum MLL-AF9
GSE7011GSM161817 serum free MLL-AF9
GSE7011GSM161813 with serum MLL-AF9
GSE7011GSM161813 with serum MLL-AF9

Tags

  • cell
  • cytokine
  • leukemia
  • serum
  • stem cell
  • umbilical cord

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use